DLH Reports Fiscal 2022 Second Quarter Results
DLH Holdings Corp. (NASDAQ: DLHC) reported a strong fiscal second quarter for 2022, achieving revenue of $108.7 million, a significant increase from $61.5 million in Q2 2021. This growth was primarily driven by two FEMA contracts worth approximately $39.8 million. Earnings were $7.2 million or $0.50 per share, up from $2.6 million or $0.19 per share year-over-year. The company reduced term debt to $37.5 million and reported a backlog of $554.7 million. Management remains optimistic about future opportunities and ongoing debt repayment.
- Revenue increased 76.4% year-over-year to $108.7 million.
- Earnings per share rose to $0.50 from $0.19 year-over-year.
- Term debt reduced to $37.5 million from $42.9 million.
- Operating margin improved to 9.4% compared to 7.5% in the prior year.
- Contract backlog stood at $554.7 million, indicating strong future revenue potential.
- None.
Revenue
Term Debt Reduced to
ATLANTA, May 04, 2022 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of innovative healthcare services and solutions to federal agencies, today announced financial results for its fiscal second quarter ended March 31, 2022.
Highlights
- Second quarter revenue increased to
$108.7 million in fiscal 2022 from$61.5 million in fiscal 2021, reflecting the previously-announced award of two FEMA contracts to support Alaska, which accounted for approximately$39.8 million of revenue - Excluding these short-term contracts, second quarter revenue rose to
$68.9 million in fiscal 2022, an increase of12% over the prior-year period - Earnings were
$7.2 million , or$0.50 per diluted share, for the fiscal 2022 second quarter versus$2.6 million , or$0.19 per diluted share, for the second quarter of fiscal 2021 - Excluding contributions from the aforementioned short-term FEMA contracts, earnings on a non-GAAP basis for the fiscal 2022 second quarter were
$3.1 million , or$0.22 per diluted share - The Company's term loan was reduced to
$37.5 million from$42.9 million during the second quarter; - Contract backlog was
$554.7 million as of March 31, 2022 versus$633.6 million at the end of the first quarter, with approximately$30.0 million of the latter related to Alaska-based task orders
Management Discussion
“Our second quarter continued the positive trends of the first, with strong organic revenue growth and contributions from our Alaska contracts resulting in solid financial performance,” said DLH President and Chief Executive Officer Zach Parker. “The overall business, net of short-term FEMA work, expanded
“With passage of the fiscal 2022 omnibus appropriations bill in March, contract decision-making should accelerate – at the same time DLH is expected to benefit from obtaining FedRamp authorization for its Infinibyte® data analytics solutions. We are pleased with the progress we are making to strengthen and diversify our capabilities across the key federal markets we serve. While focused on paying down debt and improving the balance sheet, we continue to actively look at potential acquisitions that may enhance and broaden our portfolio of technology-enabled applications. It’s an exciting time at DLH, with many opportunities ahead of us – leveraging our leadership position in innovative, healthcare-related services and solutions to build a unique, customer-centric enterprise that, at the same time, creates value for our shareholders.”
Results for the Three Months Ended March 31, 2022
Revenue for the second quarter of fiscal 2022 was
Income from operations was
Interest expense was
For the three months ended March 31, 2022 and 2021, respectively, DLH recorded a
On a non-GAAP basis, EBITDA for the three months ended March 31, 2022 was approximately
Key Financial Indicators
Fiscal year to date, DLH used
Fiscal year to date, accounts receivable increased by
As of March 31, 2022, the Company had cash of
At March 31, 2022, total backlog was approximately
Conference Call and Webcast Details
DLH management will discuss second quarter results and provide a general business update, including current competitive conditions and strategies, during a conference call beginning at 11:00 AM Eastern Time tomorrow, May 5, 2022. Interested parties may listen to the conference call by dialing 888-347-5290 or 412-317-5256. Presentation materials will also be posted on the Investor Relations section of the DLH website prior to the commencement of the conference call.
A digital recording of the conference call will be available for replay two hours after the completion of the call and can be accessed on the DLH Investor Relations website or by dialing 877-344-7529 and entering the conference ID 7532524.
About DLH
DLH (NASDAQ:DLHC) delivers improved health and readiness solutions for federal programs through research, development, and innovative care processes. The Company’s experts in public health, performance evaluation, and health operations solve the complex problems faced by civilian and military customers alike, leveraging digital transformation, artificial intelligence, advanced analytics, cloud-based applications, telehealth systems, and more. With over 2,300 employees dedicated to the idea that “Your Mission is Our Passion,” DLH brings a unique combination of government sector experience, proven methodology, and unwavering commitment to public health to improve the lives of millions. For more information, visit www.DLHcorp.com.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:
This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to future events or DLH`s future financial performance. Any statements that refer to expectations, projections or other characterizations of future events or circumstances or that are not statements of historical fact (including without limitation statements to the effect that the Company or its management “believes”, “expects”, “anticipates”, “plans”, “intends” and similar expressions) should be considered forward looking statements that involve risks and uncertainties which could cause actual events or DLH’s actual results to differ materially from those indicated by the forward-looking statements. Forward-looking statements in this release include, among others, statements regarding estimates of future revenues, operating income, earnings and cash flow. These statements reflect our belief and assumptions as to future events that may not prove to be accurate. Our actual results may differ materially from such forward-looking statements made in this release due to a variety of factors, including: the outbreak of the novel coronavirus (“COVID-19”), including the measures to reduce its spread, and its impact on the economy and demand for our services, are uncertain, cannot be predicted, and may precipitate or exacerbate other risks and uncertainties; the risk that we will not realize the anticipated benefits of acquisitions; the challenges of managing larger and more widespread operations; contract awards in connection with re-competes for present business and/or competition for new business; compliance with new bank financial and other covenants; changes in client budgetary priorities; government contract procurement (such as bid and award protests, small business set asides, loss of work due to organizational conflicts of interest, etc.) and termination risks; the ability to successfully integrate the operations of acquisitions; the impact of inflation and higher interest rates; and other risks described in our SEC filings. For a discussion of such risks and uncertainties which could cause actual results to differ from those contained in the forward-looking statements, see “Risk Factors” in the Company’s periodic reports filed with the SEC, including our Annual Report on Form 10-K for the fiscal year ended September 30, 2021, as well as subsequent reports filed thereafter. The forward-looking statements contained herein are not historical facts, but rather are based on current expectations, estimates, assumptions and projections about our industry and business.
Such forward-looking statements are made as of the date hereof and may become outdated over time. The Company does not assume any responsibility for updating forward-looking statements, except as may be required by law.
CONTACTS:
INVESTOR RELATIONS |
Contact: Chris Witty |
Phone: 646-438-9385 |
Email: cwitty@darrowir.com |
TABLES TO FOLLOW
DLH HOLDINGS CORP.
CONSOLIDATED STATEMENTS OF INCOME
(Amounts in thousands except per share amounts)
(unaudited) | (unaudited) | |||||||||||
Three Months Ended | Six Months Ended | |||||||||||
March 31, | March 31, | |||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||
Revenue | $ | 108,699 | $ | 61,506 | $ | 261,500 | $ | 119,358 | ||||
Cost of Operations: | ||||||||||||
Contract costs | 88,831 | 48,722 | 221,517 | 94,727 | ||||||||
General and administrative costs | 7,733 | 6,135 | 14,644 | 12,285 | ||||||||
Depreciation and amortization | 1,881 | 2,029 | 3,866 | 4,091 | ||||||||
Total operating costs | 98,445 | 56,886 | 240,027 | 111,103 | ||||||||
Income from operations | 10,254 | 4,620 | 21,473 | 8,255 | ||||||||
Interest expense, net | 554 | 1,004 | 1,226 | 2,084 | ||||||||
Income before income taxes | 9,700 | 3,616 | 20,247 | 6,171 | ||||||||
Income tax expense | 2,522 | 1,049 | 5,265 | 1,790 | ||||||||
Net income | $ | 7,178 | $ | 2,567 | $ | 14,982 | $ | 4,381 | ||||
Net income per share - basic | $ | 0.56 | $ | 0.20 | $ | 1.17 | $ | 0.35 | ||||
Net income per share - diluted | $ | 0.50 | $ | 0.19 | $ | 1.04 | $ | 0.32 | ||||
Weighted average common shares outstanding | ||||||||||||
Basic | 12,778 | 12,544 | 12,763 | 12,521 | ||||||||
Diluted | 14,442 | 13,570 | 14,368 | 13,568 | ||||||||
DLH HOLDINGS CORP.
CONSOLIDATED BALANCE SHEETS
(Amounts in thousands except par value of shares)
March 31, 2022 | September 30, 2021 | |||||||
(unaudited) | ||||||||
ASSETS | ||||||||
Current assets: | ||||||||
Cash | $ | 359 | $ | 24,051 | ||||
Accounts receivable | 62,152 | 33,447 | ||||||
Other current assets | 3,599 | 4,265 | ||||||
Total current assets | 66,110 | 61,763 | ||||||
Equipment and improvements, net | 1,427 | 1,912 | ||||||
Operating lease right-of-use assets | 17,999 | 19,919 | ||||||
Goodwill | 65,643 | 65,643 | ||||||
Intangible assets, net | 44,177 | 47,469 | ||||||
Other long-term assets | 398 | 464 | ||||||
Total assets | $ | 195,754 | $ | 197,170 | ||||
LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||
Current liabilities: | ||||||||
Operating lease liabilities - current | $ | 2,216 | $ | 2,261 | ||||
Accrued payroll | 12,464 | 9,125 | ||||||
Deferred revenue | — | 22,273 | ||||||
Accounts payable, accrued expenses, and other current liabilities | 44,317 | 32,717 | ||||||
Total current liabilities | 58,997 | 66,376 | ||||||
Long-term liabilities: | ||||||||
Deferred taxes, net | 1,176 | 1,176 | ||||||
Operating lease liabilities - long-term | 17,582 | 19,374 | ||||||
Debt obligations - long-term, net of deferred financing costs | 35,638 | 44,636 | ||||||
Total long-term liabilities | 54,396 | 65,186 | ||||||
Total liabilities | 113,393 | 131,562 | ||||||
Shareholders' equity: | ||||||||
Common stock, | 13 | 13 | ||||||
Additional paid-in capital | 89,664 | 87,893 | ||||||
Accumulated deficit | (7,316 | ) | (22,298 | ) | ||||
Total shareholders’ equity | 82,361 | 65,608 | ||||||
Total liabilities and shareholders' equity | $ | 195,754 | $ | 197,170 | ||||
DLH HOLDINGS CORP.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Amounts in thousands)
(unaudited) | ||||||||
Six Months Ended | ||||||||
March 31, | ||||||||
2022 | 2021 | |||||||
Operating activities | ||||||||
Net income | $ | 14,982 | $ | 4,381 | ||||
Adjustments to reconcile net income to net cash provided by (used in) operating activities: | ||||||||
Depreciation and amortization | 3,866 | 4,091 | ||||||
Amortization of deferred financing costs charged to interest expense | 319 | 413 | ||||||
Stock based compensation expense | 1,309 | 844 | ||||||
Deferred taxes, net | — | 1,512 | ||||||
Changes in operating assets and liabilities | ||||||||
Accounts receivable | (28,705 | ) | (9,134 | ) | ||||
Other current assets | 666 | 30 | ||||||
Accrued payroll | 3,339 | 1,401 | ||||||
Deferred revenue | (22,273 | ) | — | |||||
Accounts payable, accrued expenses, and other current liabilities | 11,600 | 2,245 | ||||||
Other long-term assets and liabilities | 82 | 336 | ||||||
Net cash provided by (used in) operating activities | (14,815 | ) | 6,119 | |||||
Investing activities | ||||||||
Business acquisition adjustment, net of cash acquired | — | 59 | ||||||
Purchase of equipment and improvements | (89 | ) | (53 | ) | ||||
Net cash provided by (used in) investing activities | (89 | ) | 6 | |||||
Financing activities | ||||||||
Proceeds from debt obligations | 13,500 | 18,950 | ||||||
Repayment of debt obligations | (22,750 | ) | (26,200 | ) | ||||
Payment of deferred financing costs | — | (43 | ) | |||||
Proceeds from issuance of common stock upon exercise of options and warrants | 462 | 231 | ||||||
Net cash used in financing activities | (8,788 | ) | (7,062 | ) | ||||
Net change in cash | (23,692 | ) | (937 | ) | ||||
Cash at beginning of period | 24,051 | 1,357 | ||||||
Cash at end of period | $ | 359 | $ | 420 | ||||
Supplemental disclosure of cash flow information | ||||||||
Cash paid during the period for interest | $ | 896 | $ | 1,639 | ||||
Cash paid during the period for income taxes | $ | 3,482 | $ | 184 | ||||
Revenue Metrics
Six Months Ended | ||||||
March 31, | March 31, | |||||
2022 | 2021 | |||||
Market Mix: | ||||||
Defense/VA | 29 | % | 59 | % | ||
Human Services and Solutions | 57 | % | 14 | % | ||
Public Health/Life Sciences | 14 | % | 27 | % | ||
Contract Mix: | ||||||
Time and Materials | 84 | % | 76 | % | ||
Cost Reimbursable | 9 | % | 20 | % | ||
Firm Fixed Price | 7 | % | 4 | % | ||
Prime vs Sub: | ||||||
Prime | 94 | % | 89 | % | ||
Subcontractor | 6 | % | 11 | % | ||
Non-GAAP Financial Measures
The Company uses EBITDA and EBITDA as a percent of revenue as supplemental non-GAAP measures of performance. We define EBITDA as net income excluding (i) interest expense, (ii) provision for or benefit from income taxes and (iii) depreciation and amortization. EBITDA as a percent of revenue is EBITDA for the measurement period divided by revenue for the same period.
The Company is presenting additional non-GAAP measures to describe the impact from two short-term FEMA task orders' on its financial performance for the three and six months periods ended March 31, 2022. The measures presented are revenue, operating income, net income, diluted earnings per share, and EBITDA for our enterprise contract portfolio less the respective performance on the FEMA task orders. These resulting measures present the remaining contract portfolio's quarterly financial performance compared to results delivered in the prior year period. Definitions of these additional non-GAAP measures are set forth in the footnotes to the reconciliation table below.
These non-GAAP measures of performance are used by management to conduct and evaluate its business during its review of operating results for the periods presented. Management and the Company's Board utilize these non-GAAP measures to make decisions about the use of the Company's resources, analyze performance between periods, develop internal projections and measure management performance. We believe that these non-GAAP measures are useful to investors in evaluating the Company's ongoing operating and financial results and understanding how such results compare with the Company's historical performance.
Reconciliation of GAAP net income to EBITDA, a non-GAAP measure:
Three Months Ended | Six Months Ended | |||||||||||||||||||||||
March 31, | March 31, | |||||||||||||||||||||||
(in thousands) | 2022 | 2021 | Change | 2022 | 2021 | Change | ||||||||||||||||||
Net income | $ | 7,178 | $ | 2,567 | $ | 4,611 | $ | 14,982 | $ | 4,381 | $ | 10,601 | ||||||||||||
(i) Interest expense, net | 554 | 1,004 | (450 | ) | 1,226 | 2,084 | (858 | ) | ||||||||||||||||
(ii) Provision for taxes | 2,522 | 1,049 | 1,473 | 5,265 | 1,790 | 3,475 | ||||||||||||||||||
(iii) Depreciation and amortization | 1,881 | 2,029 | (148 | ) | 3,866 | 4,091 | (225 | ) | ||||||||||||||||
EBITDA | $ | 12,135 | $ | 6,649 | $ | 5,486 | $ | 25,339 | $ | 12,346 | $ | 12,993 | ||||||||||||
Net income as a % of revenue | 6.6 | % | 4.2 | % | 2.4 | % | 5.7 | % | 3.7 | % | 2.0 | % | ||||||||||||
EBITDA as a % of revenue | 11.2 | % | 10.8 | % | 0.4 | % | 9.7 | % | 10.3 | % | (0.6)% | |||||||||||||
Revenue | $ | 108,699 | $ | 61,506 | $ | 47,193 | $ | 261,500 | $ | 119,358 | $ | 142,142 | ||||||||||||
Reconciliation of GAAP revenue, operating income, net income, diluted earnings per share, and non-GAAP EBITDA reported for the three and six months ended to the same metrics for our contract portfolio less the FEMA task orders:
Three Months Ended | Six Months Ended | |||||||||||||||||||
March 31, | March 31, | |||||||||||||||||||
( in thousands) | Ref | 2022 | 2021 | Change | 2022 | 2021 | Change | |||||||||||||
Revenue | ||||||||||||||||||||
Total enterprise | $ | 108,699 | $ | 61,506 | $ | 47,193 | $ | 261,500 | $ | 119,358 | $ | 142,142 | ||||||||
Less: FEMA task orders to support Alaska | (a) | 39,764 | — | 39,764 | 130,889 | — | 130,889 | |||||||||||||
Remaining contract portfolio | (a) | $ | 68,935 | 61,506 | 7,429 | $ | 130,611 | $ | 119,358 | $ | 11,253 | |||||||||
Operating income | ||||||||||||||||||||
Total enterprise | $ | 10,254 | $ | 4,620 | $ | 5,634 | $ | 21,473 | $ | 8,255 | $ | 13,218 | ||||||||
Less: FEMA task orders to support Alaska | (b) | 5,525 | $ | — | $ | 5,525 | 11,871 | — | 11,871 | |||||||||||
Remaining contract portfolio | (b) | $ | 4,729 | $ | 4,620 | $ | 109 | $ | 9,602 | $ | 8,255 | $ | 1,347 | |||||||
Net income | ||||||||||||||||||||
Total enterprise | $ | 7,178 | $ | 2,567 | $ | 4,611 | $ | 14,982 | $ | 4,381 | $ | 10,601 | ||||||||
Less: FEMA task orders to support Alaska | (c) | 4,089 | — | 4,089 | 8,785 | — | 8,785 | |||||||||||||
Remaining contract portfolio | (c) | $ | 3,089 | $ | 2,567 | $ | 522 | $ | 6,197 | $ | 4,381 | $ | 1,816 | |||||||
Diluted earnings per share | ||||||||||||||||||||
Total enterprise | $ | 0.50 | $ | 0.19 | $ | 0.31 | $ | 1.04 | $ | 0.32 | $ | 0.72 | ||||||||
Less: FEMA task orders to support Alaska | (d) | 0.28 | — | 0.28 | 0.61 | — | 0.61 | |||||||||||||
Remaining contract portfolio | (d) | $ | 0.22 | $ | 0.19 | $ | 0.03 | $ | 0.43 | $ | 0.32 | $ | 0.11 | |||||||
EBITDA | ||||||||||||||||||||
Total enterprise | $ | 12,135 | $ | 6,649 | $ | 5,486 | $ | 25,339 | $ | 12,346 | $ | 12,993 | ||||||||
Less: FEMA task orders to support Alaska | (e) | 5,525 | — | 5,525 | 11,871 | — | 11,871 | |||||||||||||
Remaining contract portfolio | (e) | $ | 6,610 | $ | 6,649 | $ | (39 | ) | $ | 13,468 | $ | 12,346 | $ | 1,122 |
Ref (a): Revenue for the Company’s remaining contract portfolio less the FEMA task orders represents our consolidated revenues less the revenues generated from the FEMA task orders.
Ref (b): Operating income attributable to the remaining contract portfolio less the FEMA task orders represents the Company’s consolidated operating income, determined in accordance with GAAP, less the operating income derived from the FEMA task orders. Operating income for the FEMA task orders is derived by subtracting from the revenue attributable to such task orders during the three months ended March 31, 2022 of
Ref (c): Net income attributable to the remaining contract portfolio less the FEMA task orders represents the Company’s consolidated net income, determined in accordance with GAAP, less the net income derived from the FEMA task orders. Net income for the FEMA task orders is derived by subtracting from the revenue attributable to such task orders during the three months ended March 31, 2022 of
Ref (d): Diluted earnings per share (diluted EPS) for the FEMA task orders is calculated using the net income attributable to such task orders as opposed to GAAP net income. Diluted EPS for the remaining contract portfolio (total contract portfolio excluding the FEMA task orders) is calculated by subtracting the diluted EPS for the FEMA task orders from the Company's total diluted EPS.
Ref (e): EBITDA attributable to the FEMA tasks orders of
FAQ
What were DLH's earnings for the second quarter of fiscal 2022?
How much did DLH's revenue increase in the second quarter compared to last year?
What is DLH's current term debt level?
What contributed to DLH's revenue growth in the second quarter?